Core Viewpoint - The company announces the suspension of the conversion of its convertible bonds "Hao Yuan Convertible Bonds" during the implementation of the 2025 semi-annual profit distribution plan, which includes a cash dividend of 0.80 yuan per 10 shares [2][3]. Summary by Sections 1. Securities Suspension and Resumption - The "Hao Yuan Convertible Bonds" will stop conversion from October 13, 2025, until the equity registration date for the profit distribution [2][4]. - The bonds will resume conversion on the first trading day after the equity registration date [4]. 2. Profit Distribution Plan - The company will distribute a cash dividend of 0.80 yuan (including tax) for every 10 shares based on the total share capital registered on the equity registration date [3]. - The distribution plan does not include bonus shares or capital reserve conversion into share capital [3]. - The company will adjust the conversion price of the "Hao Yuan Convertible Bonds" according to the terms outlined in the prospectus after the profit distribution [3]. 3. Additional Information - Detailed information regarding the "Hao Yuan Convertible Bonds" can be found in the prospectus disclosed on November 26, 2024 [5].
上海皓元医药股份有限公司关于实施2025年半年度权益分派时“皓元转债”停止转股的提示性公告